Company intelligence / Profile preview

Shuster Capital

Encinitas, California, United States

Ownership: Private
Development stage: Other

Overview

Shuster Capital was a strategic and operating advisory firm and angel investor specializing in the life sciences sector. Founded in 2002 by Lewis J. Shuster, the firm provided high-level guidance to biotechnology and pharmaceutical executives and investors on financial strategy, operations, and corporate development. The company played a significant role in the growth of several notable life science entities, with its founder serving on the boards of companies such as HTG Molecular Diagnostics, Principia Biopharma, and Cleave Biosciences. Shuster Capital focused on helping early-stage and public life science companies navigate rapid operational growth and strategic planning. Following the passing of its founder and CEO in 2018, the firm is no longer active.

Industry: Investors

Beyond the preview

Go deeper on Shuster Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shuster Capital.

Explore the full profile